Cargando…
Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases
Regulatory molecules have recently been recognized for their beneficial effects in the treatment of immune-mediated diseases, rather than using cytotoxic immune-suppressing drugs, which are associated with many unwanted side effects. Semaphorin3A (sema3A), a unique regulatory master of the immune sy...
Autores principales: | Eiza, Nasren, Kessler, Ofra, Sabag, Adi, Neufeld, Gera, Jones, E. Yvonne, Vadasz, Zahava |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871560/ https://www.ncbi.nlm.nih.gov/pubmed/36703747 http://dx.doi.org/10.3389/fphar.2022.1085892 |
Ejemplares similares
-
Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma
por: Adi, Sabag D., et al.
Publicado: (2019) -
The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A
por: Lobna, Matanis, et al.
Publicado: (2021) -
Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis
por: Bejar, Jacob, et al.
Publicado: (2018) -
Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus
por: Vadasz, Zahava, et al.
Publicado: (2012) -
The Expansion of CD25(high)IL-10(high)FoxP3(high) B Regulatory Cells Is in Association with SLE Disease Activity
por: Vadasz, Zahava, et al.
Publicado: (2015)